2022_Sep_ConnectinPharma_Easyfairs_Geneva

ORALLY INHALED & NASAL DRUG PRODUCTS

Issue No #17  March 1st, 2010


Download PDF


CONTENTS
Ingredient-specific particle sizing: reducing risk, cutting cost and saving time in preclinical inhalable formulation development
Dr Oksana Olkhovyk, Senior Scientist
Linda Batykefer, Marketing Manager
ChemImage Corporation
Company Profile
Coster
Optimising drug and device together for novel aerosol therapies
Dr Manfred Keller, Executive Vice-President & CSO
Dr Martin Knoch, President
PARI Pharma GmbH
Automated actuations facilitating compendial testing of nasal spray and metered dose inhaler products
Henrik G. Krarup, Vice-President, Business Development
InnovaSystems, Inc
Company Profile
Catalent Pharma Solutions
EnVision laser-based imaging system: fully characterises nasal- and dry-powder-based systems
Dr Séamus Murphy, Manager, Imaging Division
Dr Tim Stephens, Imaging Systems Engineer
Oxford Lasers Ltd
Product Profile
Büchi’s Nano Spray Dryer
Top